bioAffinity Technologies, Inc. - 8-K Filing

BioAffinity publishes clinical framework for integrating CyPath® Lung into pulmonary nodule evaluation and cancer surveillance (Items: 8.01 Other Events, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $BIAF

Read the full article at SEC EDGAR

More Regulatory news